$0.83
0.0064[0.78%]
At close: Apr 23
$0.83
0[0.00%]
PreMarket: 9:16AM EDT
Aligos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aligos Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | PM | ALGS | Q1 | -$0.53 | -$0.27 | — | — | $2.72M | — | — | — | Get Alert |
03/12/2024 | PM | ALGS | Q4 | -$0.51 | -$0.27 | -$0.22 | 18.52% | $3.54M | $1.60M | $2.01M | 25.56% | Get Alert |
11/02/2023 | PM | ALGS | Q3 | -$0.44 | -$0.47 | -$0.41 | 12.77% | $4.11M | $2.50M | $2.15M | -13.84% | Get Alert |
08/03/2023 | PM | ALGS | Q2 | -$0.47 | -$0.49 | -$0.43 | 12.24% | $3.69M | — | $2.59M | — | Get Alert |
05/04/2023 | PM | ALGS | Q1 | -$0.84 | -$0.48 | -$0.53 | -10.42% | $2.57M | — | $2.72M | — | Get Alert |
03/09/2023 | PM | ALGS | Q4 | -$0.89 | -$0.47 | -$0.51 | -8.51% | $367.00K | $1.72M | $3.54M | 105.64% | Get Alert |
11/02/2022 | PM | ALGS | Q3 | -$0.78 | -$0.58 | -$0.44 | 24.14% | $1.54M | — | $4.11M | — | Get Alert |
08/04/2022 | PM | ALGS | Q2 | -$0.79 | -$0.67 | -$0.47 | 29.85% | $1.54M | — | $3.69M | — | Get Alert |
05/04/2022 | PM | ALGS | Q1 | -$0.74 | -$0.73 | -$0.84 | -15.07% | $910.00K | — | $2.57M | — | Get Alert |
03/10/2022 | PM | ALGS | Q4 | -$1.09 | -$0.83 | -$0.89 | -7.23% | $0.00 | — | $367.00K | — | Get Alert |
11/04/2021 | PM | ALGS | Q3 | -$11.00 | -$0.81 | -$0.78 | 3.70% | $0.00 | — | $1.54M | — | Get Alert |
08/05/2021 | PM | ALGS | Q2 | — | -$0.81 | -$0.79 | 2.47% | — | — | $1.54M | — | Get Alert |
05/10/2021 | PM | ALGS | Q1 | — | -$0.90 | -$0.74 | 17.78% | — | — | $910.00K | — | Get Alert |
03/23/2021 | PM | ALGS | Q4 | -$7.27 | — | -$1.09 | — | — | — | $0.00 | — | Get Alert |
11/25/2020 | PM | ALGS | Q3 | — | — | -$11.00 | — | — | — | $0.00 | — | Get Alert |
Aligos Therapeutics (ALGS) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on March 12, 2024 for Q4.
The Actual EPS was $-0.22, which beat the estimate of $-0.27.
The Actual Revenue was $2M, which beat the estimate of $1.6M.
Browse earnings estimates, EPS, and revenue on all stocks.